A randomized clinical trial of lithium in multiple system atrophy(277 views visite) Saccà F, Marsili A, Quarantelli M, Brescia Morra V, Brunetti A, Carbone R, Pane C, Puorro G, Russo CV, Salvatore E, Tucci T, De Michele G, Filla A
Keywords Parole chiave: Clinical Trial, Lithium, Multiple System Atrophy, Phase Ii, Safety, Placebo, Adult, Aged, Article, Clinical Article, Controlled Study, Disease Course, Double Blind Procedure, Drug Blood Level, Drug Dose Increase, Drug Fatality, Drug Safety, Drug Tolerability, Drug Withdrawal, Female, Human, Priority Journal, Quality Of Life, Randomized Controlled Trial, Shy Drager Syndrome, Treatment Duration, Unspecified Side Effect, Antimanic Agents, Double-Blind Method, Middle Aged, Statistics, Nonparametric, Treatment Outcome, Antimanic Agents Therapeutic Use, Lithium Therapeutic Use, Multiple System Atrophy Drug Therapy,
Affiliations Affiliazioni: *** IBB - CNR ***
Department of Neurological Sciences, University Federico II, Via Pansini, 5, 80131 Naples, Italy Biostructure and Bioimaging Institute, National Research Council, Naples, Italy
References Riferimenti: Quinn, N., Multiple system atrophy - The nature of the beast (1989) J Neurol Neurosurg Psychiatry, (SUPPL.), pp. 78-8
Webb, J.L., Ravikumar, B., Atkins, J., Alpha-synuclein is degraded by both autophagy and the proteasome (2003) J Biol Chem, 278, pp. 25009-25013. , 12719433 10.1074/jbc.M300227200 1:CAS:528:DC%2BD3sXltVSlsbs%3D
Sarkar, S., Krishna, G., Imarisio, S., A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin (2008) Hum Mol Genet, 17, pp. 170-178. , 17921520 10.1093/hmg/ddm294 1:CAS:528:DC%2BD1cXisVWjsg%3D%3D
Verstraete, E., Veldink, J.H., Huisman, M.H., Lithium lacks effect on survival in amyotrophic lateral sclerosis: A phase IIb randomised sequential trial (2012) J Neurol Neurosurg Psychiatry, 83, pp. 557-564. , 22378918 10.1136/jnnp-2011-302021
Al-Chalabi, A., Shaw, P.J., Young, C.A., Protocol for a double-blind randomized placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) (Eudract number: 2008-006891-31) (2011) BMC Neurol, 11, p. 111. , 21936930 10.1186/1471-2377-11-111 1:CAS:528:DC%2BC3MXhtlWjsLfE
Miller, R.G., Moore, D.H., Forshew, D.A., Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design (2011) Neurology, 77, pp. 973-979. , 21813790 10.1212/WNL.0b013e31822dc7a5 1:CAS:528:DC%2BC3MXhtFCmtLbF
Aggarwal, S.P., Zinman, L., Simpson, E., Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial (2010) Lancet Neurol, 9, pp. 481-488. , 20363190 10.1016/S1474-4422(10)70068-5 1:CAS:528:DC%2BC3cXntlOmsb4%3D
Forlenza, O.V., Diniz, B.S., Radanovic, M., Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial (2011) Br J Psychiatry, 198, pp. 351-356. , 21525519 10.1192/bjp.bp.110.080044
Wenning, G.K., Tison, F., Seppi, K., Development and validation of the unified multiple system atrophy rating scale (UMSARS) (2004) Mov Disord, 19, pp. 1391-1402. , 15452868 10.1002/mds.20255
Beck, A.T., Steer, R.A., Brown, G.K., (1996) BDI-II - Beck Depression Inventory, , 2 The Psychological Corporation Harcourt Brace and Company San Antonio
Gilman, S., Wenning, G.K., Low, P.A., Second consensus statement on the diagnosis of multiple system atrophy (2008) Neurology, 71, pp. 670-676. , 18725592 10.1212/01.wnl.0000324625.00404.15 1:STN:280: DC%2BD1crktlWmsA%3D%3D
Holmberg, B., Johansson, J.O., Poewe, W., Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study (2007) Mov Disord, 22, pp. 1138-1144. , Growth-Hormone MSA Study Group
European MSA Study Group et al. 17469198 10.1002/mds.21501
Dodel, R., Spottke, A., Gerhard, A., Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [(11) C] (R)-PK11195 PET (MEMSA-trial) (2010) Mov Disord, 25, pp. 97-107. , 20014118 10.1002/mds.22732
Webb, J. L., Ravikumar, B., Atkins, J., Alpha-synuclein is degraded by both autophagy and the proteasome (2003) J Biol Chem, 278, pp. 25009-25013. , 12719433 10. 1074/jbc. M300227200 1: CAS: 528: DC%2BD3sXltVSlsbs%3D
Miller, R. G., Moore, D. H., Forshew, D. A., Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: Examining a more efficient trial design (2011) Neurology, 77, pp. 973-979. , 21813790 10. 1212/WNL. 0b013e31822dc7a5 1: CAS: 528: DC%2BC3MXhtFCmtLbF
Aggarwal, S. P., Zinman, L., Simpson, E., Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial (2010) Lancet Neurol, 9, pp. 481-488. , 20363190 10. 1016/S1474-4422 (10) 70068-5 1: CAS: 528: DC%2BC3cXntlOmsb4%3D
Forlenza, O. V., Diniz, B. S., Radanovic, M., Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial (2011) Br J Psychiatry, 198, pp. 351-356. , 21525519 10. 1192/bjp. bp. 110. 080044
Wenning, G. K., Tison, F., Seppi, K., Development and validation of the unified multiple system atrophy rating scale (UMSARS) (2004) Mov Disord, 19, pp. 1391-1402. , 15452868 10. 1002/mds. 20255
Beck, A. T., Steer, R. A., Brown, G. K., (1996) BDI-II - Beck Depression Inventory, , 2 The Psychological Corporation Harcourt Brace and Company San Antonio
A randomized clinical trial of lithium in multiple system atrophy
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(187 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G * CaMK4 gene deletion induces hypertension(274 visite) J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D. Impact Factor:2.882 DettagliEsporta in BibTeXEsporta in EndNote
Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP, Valzania F, Fagioli G, Distefano A, Bagnato A, Feggi L, Anna S, Maria Teresa Rosaria De Cr, Nobili F, Mazzuca N, Baldari S, Eleopra R, Bestetti A, Benti R, Varrone A, Volterrani D, Massa R, Stocchi F, Schillaci O, Dore F, Zibetti M, Castellano G, Battista SG, Giorgetti G * The relationship between cerebral vascular disease and parkinsonism: The VADO study(399 visite) Parkinsonism Relat D (ISSN: 1353-8020, 1873-5126, 1873-5126electronic), 2012; 18(6): 775-780. Impact Factor:3.274 DettagliEsporta in BibTeXEsporta in EndNote
Malvindi MA, Greco A, Conversano F, Figuerola A, Corti M, Bonora M, Lascialfari A, Doumari HA, Moscardini M, Cingolani R, Gigli G, Casciaro S, Pellegrino T, Ragusa A * MR Contrast Agents(217 visite) Small Animal Imaging, 2011 Jul 8; 21(13): 2548-2555. Impact Factor:1.784 DettagliEsporta in BibTeXEsporta in EndNote
Bruni AC, Bernardi L, Colao R, Rubino E, Smirne N, Frangipane F, Terni B, Curcio SA, Mirabelli M, Clodomiro A, Di Lorenzo R, Maletta R, Anfossi M, Gallo M, Geracitano S, Tomaino C, Muraca MG, Leotta A, Lio SG, Pinessi L, Rainero I, Sorbi S, Nee L, Milan G, Pappata S, Postiglione A, Abbamondi N, Forloni G, St George Hyslop P, Rogaeva E, Bugiani O, Giaccone G, Foncin JF, Spillantini MG, Puccio G * Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation(383 visite) Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2010 Mar 9; 74(10): 798-806. Impact Factor:8.017 DettagliEsporta in BibTeXEsporta in EndNote